TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

MAXIDEX

DEXAMETHASONE Corticosteroid Hormone Receptor Agonists
Immunology Approved 1962-06-20
2
Indications
--
Phase 3 Trials
63
Years on Market

Details

Status
Prescription
First Approved
1962-06-20
Routes
OPHTHALMIC
Dosage Forms
SUSPENSION/DROPS, OINTMENT

Companies

Active Ingredient: DEXAMETHASONE

MAXIDEX Approval History

Loading approval history...

What MAXIDEX Treats

9 indications

MAXIDEX is approved for 9 conditions since its original approval in 1962. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Inflammatory Conditions
  • Allergic Conjunctivitis
  • Acne Rosacea
  • Superficial Punctate Keratitis
  • Herpes Zoster Keratitis
  • Iritis
  • Cyclitis
  • Infective Conjunctivitis
Source: FDA Label

Drugs Similar to MAXIDEX

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

LOTEPREDNOL ETABONATE
LOTEPREDNOL ETABONATE
7 shared
SENTISS
Shared indications:
Inflammatory ConditionsAllergic ConjunctivitisSuperficial Punctate Keratitis +4 more
LOTEPREDNOL ETABONATE AND TOBRAMYCIN
LOTEPREDNOL ETABONATE
6 shared
ALEMBIC
Shared indications:
Allergic ConjunctivitisSuperficial Punctate KeratitisHerpes Zoster Keratitis +3 more
ZYLET
LOTEPREDNOL ETABONATE
6 shared
BAUSCH AND LOMB
Shared indications:
Allergic ConjunctivitisAcne RosaceaSuperficial Punctate Keratitis +3 more
MAXITROL
DEXAMETHASONE
2 shared
HARROW EYE
Shared indications:
Infective ConjunctivitisCorneal Injury
NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE
BACITRACIN ZINC
2 shared
BAUSCH AND LOMB
Shared indications:
Infective ConjunctivitisCorneal Injury
ACULAR
KETOROLAC TROMETHAMINE
1 shared
AbbVie
Shared indications:
Allergic Conjunctivitis
ALREX
LOTEPREDNOL ETABONATE
1 shared
BAUSCH AND LOMB
Shared indications:
Allergic Conjunctivitis
BEPOTASTINE BESILATE
BEPOTASTINE BESILATE
1 shared
SOMERSET THERAPS LLC
Shared indications:
Allergic Conjunctivitis
BEPREVE
BEPOTASTINE BESILATE
1 shared
BAUSCH AND LOMB INC
Shared indications:
Allergic Conjunctivitis
CARBINOXAMINE MALEATE
CARBINOXAMINE MALEATE
1 shared
MIKART
Shared indications:
Allergic Conjunctivitis
DEXTENZA
DEXAMETHASONE
1 shared
OCULAR THERAPEUTIX
Shared indications:
Allergic Conjunctivitis
KARBINAL ER
CARBINOXAMINE MALEATE
1 shared
AYTU
Shared indications:
Allergic Conjunctivitis
PROMETHAZINE HYDROCHLORIDE; CODEINE PHOSPHATE
PROMETHAZINE HYDROCHLORIDE
1 shared
CHARTWELL RX
Shared indications:
Allergic Conjunctivitis
PROMETHAZINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
PROMETHAZINE HYDROCHLORIDE
1 shared
COSETTE
Shared indications:
Allergic Conjunctivitis
PROMETHAZINE PLAIN
PROMETHAZINE HYDROCHLORIDE
1 shared
PHARMOBEDIENT
Shared indications:
Allergic Conjunctivitis
PROMETHEGAN
PROMETHAZINE HYDROCHLORIDE
1 shared
COSETTE
Shared indications:
Allergic Conjunctivitis
TOBRADEX
DEXAMETHASONE
1 shared
Novartis
Shared indications:
Corneal Injury
TOBRADEX ST
DEXAMETHASONE
1 shared
HARROW EYE
Shared indications:
Corneal Injury
ZERVIATE
CETIRIZINE HYDROCHLORIDE
1 shared
HARROW EYE
Shared indications:
Allergic Conjunctivitis
๐Ÿ”ฌ

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
โญ

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
๐Ÿ“Š

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

MAXIDEX FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

Steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe, such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation; corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies.

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.